Madam Chair, let me start by saying that I was as disappointed as anyone with the turn of events related to the CHVI, but I am quite excited by the opportunity that we have before us, in that the Gates Foundation is continuing in its commitment to this initiative, as is the Government of Canada. To me, the biggest obstacle to the development of an HIV vaccine is, as I understand, a natural immunity to HIV. For all vaccines we have some kind of knowledge of what natural immunity is all about. So we know, for instance, that if you get natural measles, you are immune to measles for the rest of your life, pretty much. So you can make a vaccine based on that knowledge. For HIV, we don't have that kind of understanding.
I think that Canada has been a leader in trying to understand natural immunity to HIV, and I believe that investing the $88 million that was to go to a not-needed bricks and mortar facility will allow the science to advance more rapidly and to allow Canadian leadership in this field.